The FDA granted fast track designation to PAS-004, a macrocyclic MEK inhibitor, for NF1-associated plexiform neurofibromas ...

Fast Track Designation highlights potential of CTIM-76 to address unmet need for patients with PROCCTIM-76 Phase 1a trial ongoing, with interim ...

Cocrystal Pharma, Inc. COCP shares are trading higher Thursday after the company announced that it has received Fast Track ...

FDA Fast Track designation supports accelerated development and expedites regulatory reviewNorovirus is responsible for an ...

The FDA has granted Fast Track Designation to CTIM-76, a claudin-6 (CLDN6) x CD3 T cell engaging bispecific antibody, for the ...

Detailed price information for Pasithea Therapeutics Corp (KTTA-Q) from The Globe and Mail including charting and trades.

Context Therapeutics (CNTX) added ~11% on Thursday after the cancer drug developer said that the U.S. Food and Drug Administration (FDA) issued its Fast Track Designation to CTIM-76, the lead asset of ...

Shares of Context Therapeutics rose after the Food and Drug Administration moved to expedite its review of the biopharmaceutical company's treatment for ovarian cancer. The stock climbed 8.7% to $2.88 ...

Add Yahoo as a preferred source to see more of our stories on Google. The therapy is being evaluated in the ongoing Phase I/II UPBEAT clinical trial in BAG3 DCM patients. Credit: NMK-Studio / ...

"We are pleased that the FDA has granted Fast Track designation for CDI-988, marking a significant milestone for Cocrystal ...

Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...